Health officials in Washington state recently announced an investigation into a similar local case in the Tacoma area.
A genomic study of malaria samples from Tanzania and Zanzibar found mutations connected to artemisinin partial resistance, which can lead to poor treatment outcomes.
The trial showed a community-wide benefit with ivermectin compared with the comparison drug albendazole.
The drug fills a treatment gap for the youngest babies, who are too young to be vaccinated.
Women and young adults aged 15 to 49 experienced a greater burden of mental illness.
The preventable deaths include those of 4.5 million preschool children.
US officials confirm the nation's first H5N1 avian flu detection in US dairy cattle in 3 weeks.
The chemical compound blocks malaria parasite transmission in mosquitoes without contributing to insecticide resistance.
Mali, the 20th African country to introduce malaria vaccination, will use a hybrid approach to boost protection during the high-risk part of the season.
In related news, the WHO marks World Malaria Day with a warning that progress against the mosquito-borne disease is stalling.
